Are these 2 compelling ASX shares buys in May 2022?
Temple & Webster and the ESPO ETF may be compelling ASX shares in May 2022. The post Are these 2 compelling ASX shares buys in
May 4, 2022
May 4, 2022
Menu
The Fortescue share price is down 8% in May. Is now the time to buy?
What’s dragging Fortescue shares lower? The post The Fortescue share price is down 8% in May. Is now the time to buy? appeared first on
May 4, 2022
Why the Stock Market Soared Wednesday
The stock market soared on Wednesday, finally bouncing back from more than a month of selling pressure. With investors having feared rising inflation, geopolitical challenges,
May 4, 2022
If you’d bought $5,000 of Lynas shares 5 years ago, guess how much you’d have now
How much would you have pocketed if you had picked Lynas shares five years ago? The post If you’d bought $5,000 of Lynas shares 5
May 4, 2022
Why Marriott International Stock Blasted Higher Today
What happened Wednesday was a fine day to be a Marriott International (NYSE: MAR) shareholder. The company not only posted estimate-busting first-quarter results, but it
May 4, 2022
NAB share price on watch amid $3,480 million half-year cash profit
NAB has reported a half-year cash profit of $3,480 million… The post NAB share price on watch amid $3,480 million half-year cash profit appeared first
May 4, 2022
Why Lyft Stock Crashed Today
What happened Shares of Lyft (NASDAQ: LYFT) plummeted 30% on Wednesday after the ride-sharing company warned investors that paying up to retain drivers would weigh heavily on
May 4, 2022
ANZ shares downgraded after cost cutting plan abandoned
ANZ shares have been downgraded by Goldman Sachs… The post ANZ shares downgraded after cost cutting plan abandoned appeared first on The Motley Fool Australia.
May 4, 2022
Analysts name 2 inflation-beating ASX dividend shares to buy
Here are two dividend shares rated as buys… The post Analysts name 2 inflation-beating ASX dividend shares to buy appeared first on The Motley Fool
May 4, 2022
Why Moderna Stock Jumped Today
What happened Shares of Moderna (NASDAQ: MRNA) rose 5.8% on Wednesday after the pharmaceutical leader delivered an impressive first-quarter report. So what Moderna’s revenue soared 213% to
May 4, 2022
Trade The World Anywhere & Anytime!
Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.
Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.
Refer Your Friends
Tell your friends about Monex and gift them FREE access to our trading tools.
We respect your privacy and will only send this one email notification to your friends.
Share With Your Friends
